Replies to post #1990 on Galectin Therapeutics Inc. (GALT)

[Tesla1]

The CX Trial requires measuring hepatic venous pressure which is done by inserting a catheter into a hepatic vein so it would be likely that patients are going to receive some Versed. It looks like the FDA wanted to first know if Versed and GRMD02 would have adverse interactions